Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02852434 · ClinicalTrials.gov registry record · Phase 3
Self-administered Lidocaine Gel for Pain-control During Cervical Preparation for Dilation and Evacuation
A Phase 3 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 3
- Development phase
- 72
- Enrollment target
NCT02852434: Completed Phase 3 study, sponsored by Stanford University.
NCT02852434 is a Phase 3 study that has completed, run by Stanford University. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02852434, a Phase 3 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 72 participants
- Enrollment target
Study Summary
This study seeks to compare self-administered lidocaine gel for pain control during cervical preparation for dilation and evacuation (D\&E) to paracervical block.
Interventions
- DRUG Lidocaine Gel (2%)
- DRUG Lidocaine Paracervical Block (1%)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02852434
The ClinicalTrials.gov registry entry for NCT02852434 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lidocaine Gel (2%) is the first listed.
NCT02852434 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02852434 about?
NCT02852434 is a clinical study titled "Self-administered Lidocaine Gel for Pain-control During Cervical Preparation for Dilation and Evacuation". This study seeks to compare self-administered lidocaine gel for pain control during cervical preparation for dilation and evacuation (D\&E) to paracervical block.
What is the current status of trial NCT02852434?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 72 participants. The study started on 2016-07. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02852434?
The interventions under investigation include: Lidocaine Gel (2%) (DRUG), Lidocaine Paracervical Block (1%) (DRUG).
Who is sponsoring clinical trial NCT02852434?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.